Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2000-08-18
2004-12-14
Celsa, Bennett (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S069100, C435S069700, C435S243000, C435S320100, C435S456000, C435S475000, C435S477000
Reexamination Certificate
active
06830885
ABSTRACT:
BACKGROUND OF THE INVENTION
a) Field of the Invention
The present invention relates to screening of nucleic acids. More particularly, the present invention is concerned with the identification of nucleic acids having a desired feature, such as nucleic acids encoding signal peptides, secreted proteins, membrane bound proteins, proteases and drug-resistance proteins.
b) Brief Description of the Prior Art
Large-scale gene sequencing projects are currently generating huge amounts of genetic information. Biomedical research is therefore faced with the challenge of deciphering this genetic information. This is usually done with the help of functional genomic tools. There are currently two main approaches to massively analyze gene function. The first one involves determining the expression profile of genes in normal and diseased tissues. This approach only gives circumstantial evidence to gene function and allows at best the formulation of hypotheses with respect to the function of differentially expressed genes. The other approach is a more biological approach and it uses model organism or cell-based assays to selectively identify genes possessing a chosen biological property or function. Both approaches are complementary and ultimately converge toward the characterization of therapeutically useful genes.
Cell-based screening technology can be viewed as a tool that sends out a positive “signal” if, and only if, a particular “target” gene possessing the activity being screened for has been incorporated into a cell. This technology is based on a reporter system that is kept inactive in the absence of the target gene. Although the nature of the reporter and the conditions upon which it is activated may vary, the reporter systems typically involve the synthesis of either marker proteins (e.g. antibodies), proteins necessary for cell survival under selective conditions (e.g. aminoglycoside3′ phosphotransferase), or fluorescent tags such as green fluorescent protein. In every case, a cell selection procedure is required to identify the gene which has activated the reporter. When screening is conducted with micro-organisms (e.g.
Escherchia coli, Saccharomyces cerevisiae
), the cell selection step is relatively straightforward. However, mammalian cells are the model of choice to study genes involved in human diseases and, unlike micro-organisms, mammalian cells cannot be easily selected in culture. Methods for selecting mammalian cells either require sophisticated and expensive hardware (e.g. fluorescence-activated cell sorting) or are lengthy and susceptible to high percentages of false-positives due to mutation/adaptation (growth of cells in selective medium). Furthermore, these known methods cannot greatly amplify the exogenous nucleic acid encoding a protein of interest since it gives rise to at most a few cells in which the reporter has been activated.
Viruses have been used for many years to introduce and express exogenous coding sequences in a host cell. Among the viruses used, recombinant Sindbis virus described in U.S. Pat. No 5,217,879 is particularly useful since it can infect cells from various different tissues and express an exogenous coding sequence at relatively high levels. Recently, the scientific community has foreseen the potential of viruses in gene screening methods, particularly as a mean to introduce genes into mammalian cells. International patent application No. PCT/US99/01164 published under No. WO99/36516 describes the use of virus vectors for selecting desired functions of RNAs and proteins. Similarly, International patent application No. PCT/US98/24520 published under No. WO99/25876 describes a method for the detection, characterization and isolation of nucleic acids encoding proteins of a desired property. These methods are based on the expression of high levels of an exogenous protein in a cell and on the marking or observance of the exogenous protein so produced to determine its function. Therefore, the methods described in these two international applications are different from the present invention. Indeed, these international applications do not describe a method wherein viral particles are produced only once an exogenous nucleic acid having a desired property has been inserted into a viral genome. They do not describe either a nucleic acid molecule encoding a dysfunctional viral genome wherein production of a viral particle is dependent on insertion into the dysfunctional viral genome of an exogenous nucleic acid having a desired property such as a nucleic acid encoding a signal peptide, a secreted protein, a membrane protein, a protease or a drug-resistance protein.
In view of the above, it is clear that there is a need for methods and tools which overcome the limits and obviate the problems known in the art. More particularly, there is a need for a gene screening method that bypasses the time-consuming cell selection step and that does not require marking of proteins. The purpose of this invention is to fulfill these needs by taking advantage of the natural property of viruses to incorporate and export genetic material out of a cell. The purpose of this invention is also to fulfil other needs that will be apparent to those skilled in the art upon reading the following specification.
SUMMARY OF THE INVENTION
It is therefore an object of the present invention to provide a molecule, a method and a kit for selecting a nucleic acid having a desired feature. More particularly, it is an object of the invention to provide a modified viral genome capable of both expressing exogenous nucleic acids within a host and selecting among these nucleic acids the ones having a desired feature, a predefined characteristic or function. Such nucleic acids include nucleic acids encoding a signal peptide, nucleic acids encoding at least partially for a protein having a signal peptide, nucleic acids encoding proteases, nucleic acids encoding proteins or peptides having a proteolytic activity and nucleic acids encoding drug-resistance proteins or peptides.
In one aspect, the invention is directed to a method for selecting a nucleic acid having a desired feature and the method comprises the steps of:
a) providing a viral genome capable, when present into a suitable host, of expressing an exogenous nucleic acid inserted therein and also capable of packaging itself into a viral particle;
b) providing a suppressive condition wherein the viral genome is capable of packaging itself into a viral particle only once said suppressive condition is being overcome;
c) inserting an exogenous nucleic acid into the viral genome to provide a recombinant viral genome;
d) transfecting the recombinant viral genome into a suitable host; and
e) allowing the recombinant viral genome to express said exogenous nucleic acid and package itself into a recombinant viral particle. The production of at least one recombinant viral particle is then indicative that the suppressive condition has been overcome and that the exogenous nucleic acid inserted in step c) has the desired feature.
Preferably, the suppressive condition is provided by modifying the viral genome in order to inactivate a viral gene product involved in the packaging of the viral particle(s). The viral genome can also be modified to abolish its autoreplicative functions(s) and/or the infectivity of viral particles produced therefrom.
In one embodiment, the viral genome is modified in order to encode a dysfunctional signal peptide and the production of a viral particle is dependent on insertion into said viral genome of an exogenous nucleic acid encoding a functional signal peptide or at least partially a protein having a signal peptide. It is therefore possible to select a nucleic acid encoding a signal peptide or a protein having a signal peptide using the method of the invention. The present invention thus also provides a method for selecting a nucleic acid encoding a signal peptide or a protein having a signal peptide, this method comprising the steps of:
a) providing a viral genome modified in order to encode a dysfunctional signal
Lanctot Christian
Moffat Pierre
Salois Patrick
Celsa Bennett
Epperson Jon D.
Herschbach Jarrell Brenda
Lyon Charles E.
Phenogene Therapeutiques Inc.
LandOfFree
Nucleic acid molecule, method and kit for selecting a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid molecule, method and kit for selecting a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid molecule, method and kit for selecting a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3325330